4.7 Article

Detection algorithm for the validation of human cell lines

期刊

INTERNATIONAL JOURNAL OF CANCER
卷 131, 期 6, 页码 E1024-E1030

出版社

WILEY-BLACKWELL
DOI: 10.1002/ijc.27533

关键词

short tandem repeat (STR); cell line validation

类别

资金

  1. Kleberg Center for Molecular Markers
  2. Characterized Cell Line core
  3. Molecular Cytogenetics Facility, NCI [CA16672]
  4. Characterized Cell Line core, NCI
  5. AstraZeneca
  6. Celgene
  7. CeMines
  8. Exelixis
  9. GlaxoSmithKline
  10. LPath
  11. Roche
  12. Wyeth/Pfizer

向作者/读者索取更多资源

Cell lines are an important tool in understanding all aspects of cancer growth, development, metastasis and tumor cell death. There has been a dramatic increase in the number of cell lines and diversity of the cancers they represent; however, misidentification and cross-contamination of cell lines can lead to erroneous conclusions. One method that has gained favor for authenticating cell lines is the use of short tandem repeats (STR) to generate a unique DNA profile. The challenge in validating cell lines is the requirement to compare the large number of existing STR profiles against cell lines of interest, particularly when considering that the profiles of many cell lines have drifted over time and original samples are not available. We report here methods that analyze the variations and the proportional changes extracted from tetra-nucleotide repeat regions in the STR analysis. This technique allows a paired match between a target cell line and a reference database of cell lines to find cell lines that match within a user designated percentage cut-off quality matrix. Our method accounts for DNA instability and can suggest whether the target cell lines are misidentified or unstable.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Multidisciplinary Sciences

Characterization of twenty-five ovarian tumour cell lines that phenocopy primary tumours

Tan A. Ince, Aurea D. Sousa, Michelle A. Jones, J. Chuck Harrell, Elin S. Agoston, Marit Krohn, Laura M. Selfors, Wenbin Liu, Ken Chen, Mao Yong, Peter Buchwald, Bin Wang, Katherine S. Hale, Evan Cohick, Petra Sergent, Abigail Witt, Zhanna Kozhekbaeva, Sizhen Gao, Agoston T. Agoston, Melissa A. Merritt, Rosemary Foster, Bo R. Rueda, Christopher P. Crum, Joan S. Brugge, Gordon B. Mills

NATURE COMMUNICATIONS (2015)

Article Biochemical Research Methods

Dielectrophoresis has broad applicability to marker-free isolation of tumor cells from blood by microfluidic systems

Sangjo Shim, Katherine Stemke-Hale, Jamileh Noshari, Frederick F. Becker, Peter R. C. Gascoyne

BIOMICROFLUIDICS (2013)

Article Biochemical Research Methods

Antibody-independent isolation of circulating tumor cells by continuous-flow dielectrophoresis

Sangjo Shim, Katherine Stemke-Hale, Apostolia M. Tsimberidou, Jamileh Noshari, Thomas E. Anderson, Peter R. C. Gascoyne

BIOMICROFLUIDICS (2013)

Article Oncology

A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation

Kimberly C. Wiegand, Bryan T. Hennessy, Samuel Leung, Yemin Wang, Zhenlin Ju, Mollianne McGahren, Steve E. Kalloger, Sarah Finlayson, Katherine Stemke-Hale, Yiling Lu, Fan Zhang, Michael S. Anglesio, Blake Gilks, Gordon B. Mills, David G. Huntsman, Mark S. Carey

BMC CANCER (2014)

Article Oncology

Breast cancer, side population cells and ABCG2 expression

K. M. Britton, R. Eyre, I. J. Harvey, K. Stemke-Hale, D. Browell, T. W. J. Lennard, A. P. Meeson

CANCER LETTERS (2012)

Meeting Abstract Oncology

Evaluation of PTEN and PIK3CA status in breast cancer for patient selection: Cross-validation between institutions

Violeta Serra, Jordi Rodon, Ludmila Prudkin, Claudia Aura, Ana Vivancos, Yasir H. Ibrahim, Mathew Maurer, Hanina Hibshoosh, Katherine Stemke-Hale, Jose Jimenez, Yuker Wang, Vicente Peg, Javier Hernandez, Santiago Ramon Y Cajal, Rodrigo Dienstmann, Cristina Saura, Gessami Sanchez, Josep Tabernero, Ramon Parsons, Gordon Mills, Jose Baselga

CANCER RESEARCH (2012)

Meeting Abstract Oncology

Paradoxical activation of the RAF-MEK-ERK pathway in response to nilotinib induces synthetic lethality with MEK inhibition in head and neck cancer cells

Banibrata Sen, Tuhina Mazumdar, Shaohua Peng, Katherine S. Hale, Bonnie S. Glisson, Faye M. Johnson

CANCER RESEARCH (2013)

Article Oncology

The RAC1 P29S Hotspot Mutation in Melanoma Confers Resistance to Pharmacological Inhibition of RAF

Ian R. Watson, Liren Li, Peter K. Cabeceiras, Mozhdeh Mahdavi, Tony Gutschner, Giannicola Genovese, Guocan Wang, Zhuangna Fang, James M. Tepper, Katherine Stemke-Hale, Kenneth Y. Tsai, Michael A. Davies, Gordon B. Mills, Lynda Chin

CANCER RESEARCH (2014)

Article Biochemical Research Methods

Correlations between the dielectric properties and exterior morphology of cells revealed by dielectrophoretic field-flow fractionation

Peter R. C. Gascoyne, Sangjo Shim, Jamileh Noshari, Frederick F. Becker, Katherine Stemke-Hale

ELECTROPHORESIS (2013)

Article Pathology

Frequency of mutations and polymorphisms in borderline ovarian tumors of known cancer genes

Katherine Stemke-Hale, Kristy Shipman, Isidora Kitsou-Mylona, David G. de Castro, Vicky Hird, Robert Brown, James Flanagan, Hani Gabra, Gordon B. Mills, Roshan Agarwal, Mona El-Bahrawy

MODERN PATHOLOGY (2013)

Article Oncology

A Comprehensive Evaluation of Biomarkers Predictive of Response to PI3K Inhibitors and of Resistance Mechanisms in Head and Neck Squamous Cell Carcinoma

Tuhina Mazumdar, Lauren A. Byers, Patrick Kwok Shing Ng, Gordon B. Mills, Shaohua Peng, Lixia Diao, You-Hong Fan, Katherine Stemke-Hale, John V. Heymach, Jeffrey N. Myers, Bonnie S. Glisson, Faye M. Johnson

MOLECULAR CANCER THERAPEUTICS (2014)

Article Biochemistry & Molecular Biology

Genetic Variation in the PNPLA3 Gene and Hepatocellular Carcinoma in USA: Risk and Prognosis Prediction

Manal M. Hassan, Ahmed Kaseb, Carol J. Etzel, Hashem El-Serag, Margaret R. Spitz, Ping Chang, Katherine S. Hale, Mei Liu, Asif Rashid, Mohamed Shama, James L. Abbruzzese, Evelyne M. Loyer, Harmeet Kaur, Hesham M. Hassabo, Jean-Nicolas Vauthey, Curtis J. Wray, Basmah S. Hassan, Yehuda Z. Patt, Ernest Hawk, Khalid M. Soliman, Donghui Li

MOLECULAR CARCINOGENESIS (2013)

Article Multidisciplinary Sciences

Gene Expression Profiling of Ampullary Carcinomas Classifies Ampullary Carcinomas into Biliary-Like and Intestinal-Like Subtypes That Are Prognostic of Outcome

Michael J. Overman, Jiexin Zhang, Scott Kopetz, Michael Davies, Jiang Zhi-Qin, Katherine Stemke-Hale, Petra Ruemmele, Christian Pilarsky, Robert Gruetzmann, Stanley Hamilton, Rosa Hwang, James L. Abbruzzese, Gauri Varadhachary, Bradley Broom, Huamin Wang

PLOS ONE (2013)

Article Oncology

Reversing paclitaxel resistance in ovarian cancer cells via inhibition of the ABCB1 expressing side population

Rachel Eyre, Ian Harvey, Katherine Stemke-Hale, Thomas W. J. Lennard, Alison Tyson-Capper, Annette P. Meeson

TUMOR BIOLOGY (2014)

Article Multidisciplinary Sciences

Inferring tumour purity and stromal and immune cell admixture from expression data

Kosuke Yoshihara, Maria Shahmoradgoli, Emmanuel Martinez, Rahulsimham Vegesna, Hoon Kim, Wandaliz Torres-Garcia, Victor Trevino, Hui Shen, Peter W. Laird, Douglas A. Levine, Scott L. Carter, Gad Getz, Katherine Stemke-Hale, Gordon B. Mills, Roel G. W. Verhaak

NATURE COMMUNICATIONS (2013)

Article Oncology

Anal cancer screening results from 18-to-34-year-old men who have sex with men living with HIV

Yuxin Liu, Swati Bhardwaj, Keith Sigel, John Winters, Joseph Terlizzi, Michael M. Gaisa

Summary: This study investigated the prevalence and severity of anal HPV disease among MSM LWH under the age of 35, finding a high prevalence of HPV infection and precancer but no cases of invasive anal cancer. This supports the adoption of age-based anal cancer screening for this population.

INTERNATIONAL JOURNAL OF CANCER (2024)